Rachel A Stahler Organon & Co. (OGN) insider trading activity

Rachel A Stahler is Chief Information Officer of Organon & Co.. Currently has a direct ownership of 77,230 shares of OGN, which is worth approximately $1.15 Million. The most recent transaction as insider was on Mar 31, 2025, when has been sold 7,217 shares (Common Stock) at a price of $14.51 per share, resulting in proceeds of $104,718. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 77.2K

53.89% 3M change

67.05% 12M change

Total Value Held $1.15 Million

Rachel A Stahler Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2025	SELL Payment of exercise price or tax liability	$104,718 $14.51 p/Share	7,217 Reduced 8.55%	77,230 Common Stock
Mar 31 2025	BUY Exercise of conversion of derivative security	-	18,334 Added 18.84%	78,993 Common Stock
Feb 20 2025	SELL Payment of exercise price or tax liability	$91,007 $15.11 p/Share	6,023 Reduced 8.35%	66,113 Common Stock
Feb 20 2025	BUY Grant, award, or other acquisition	-	16,608 Added 21.22%	61,652 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$33,475 $20.35 p/Share	1,645 Reduced 3.17%	50,186 Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	-	3,594 Added 6.48%	51,831 Common Stock
May 04 2024	SELL Payment of exercise price or tax liability	$20,492 $19.61 p/Share	1,045 Reduced 2.12%	48,237 Common Stock
May 04 2024	BUY Exercise of conversion of derivative security	-	3,049 Added 5.83%	49,282 Common Stock
Mar 31 2024	SELL Payment of exercise price or tax liability	$65,254 $18.8 p/Share	3,471 Reduced 6.98%	46,233 Common Stock
Mar 31 2024	BUY Grant, award, or other acquisition	-	10,132 Added 17.29%	48,478 Common Stock
Feb 28 2024	SELL Payment of exercise price or tax liability	$78,041 $18.04 p/Share	4,326 Reduced 9.85%	39,572 Common Stock
Feb 28 2024	BUY Exercise of conversion of derivative security	-	12,117 Added 21.63%	43,898 Common Stock
Aug 05 2023	SELL Payment of exercise price or tax liability	$95,119 $21.53 p/Share	4,418 Reduced 12.2%	31,781 Common Stock
Aug 05 2023	BUY Exercise of conversion of derivative security	-	12,895 Added 26.27%	36,199 Common Stock
May 04 2023	SELL Payment of exercise price or tax liability	$25,306 $24.24 p/Share	1,044 Reduced 4.29%	23,304 Common Stock
May 04 2023	BUY Exercise of conversion of derivative security	-	3,046 Added 11.12%	24,348 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$28,308 $23.09 p/Share	1,226 Reduced 5.44%	21,302 Common Stock
Mar 31 2023	BUY Exercise of conversion of derivative security	-	3,578 Added 13.71%	22,528 Common Stock
Aug 05 2022	SELL Payment of exercise price or tax liability	$143,123 $32.41 p/Share	4,416 Reduced 18.9%	18,950 Common Stock
Aug 05 2022	BUY Exercise of conversion of derivative security	-	12,890 Added 35.55%	23,366 Common Stock
May 04 2022	SELL Payment of exercise price or tax liability	$33,867 $32.44 p/Share	1,044 Reduced 9.06%	10,476 Common Stock
May 04 2022	BUY Exercise of conversion of derivative security	-	3,046 Added 20.91%	11,520 Common Stock
Aug 05 2021	SELL Payment of exercise price or tax liability	$126,430 $28.63 p/Share	4,416 Reduced 34.26%	8,474 Common Stock
Aug 05 2021	BUY Exercise of conversion of derivative security	$369,041 $28.63 p/Share	12,890 Added 50.0%	12,890 Common Stock

Also insider at

NEO

NEOGENOMICS INC Healthcare

Director

RAS

Rachel A Stahler

Chief Information Officer

Jersey City,, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OGN shares.

Notify only if

Value

Insider Trading

Get notified when an Organon & Co. insider buys or sells OGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Organon & Co.

Track Activities on OGN

Account